Konstantinopoulos et al. 28 defined a BRCAness gene signature by comparing transcriptomic profiles between BRCA1/2 mutant and sporadic ovarian tumor samples, and applied it to classify sporadic ovarian tumors. The gene discussed is BRCA1; the disease is ovarian neoplasm.